Ivan Goldberg Selected Research

Ganfort

1/2015	Efficacy of a preservative-free formulation of fixed-combination bimatoprost and timolol (Ganfort PF) in treatment-naïve patients vs previously treated patients.
7/2014	Bimatoprost 0.03%/timolol 0.5% preservative-free ophthalmic solution versus bimatoprost 0.03%/timolol 0.5% ophthalmic solution (Ganfort) for glaucoma or ocular hypertension: a 12-week randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ivan Goldberg Research Topics

Disease

40	Glaucoma 11/2021 - 10/2002
14	Ocular Hypertension (Glaucoma, Suspect) 01/2021 - 06/2002
13	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2021 - 06/2002
4	Hyperemia 01/2021 - 10/2002
3	Ganglion Cysts (Ganglion) 03/2016 - 09/2013
3	Cataract (Cataracts) 01/2013 - 10/2005
2	Hypersensitivity (Allergy) 09/2017 - 08/2007
2	Optic Nerve Diseases (Optic Neuropathy) 01/2016 - 10/2002
2	Choroidal Effusions 07/2014 - 05/2012
2	Blindness (Hysterical Blindness) 06/2013 - 01/2013
1	Inflammation (Inflammations) 12/2023
1	Genetic Risk Score 01/2020
1	Macular Degeneration (Age-Related Maculopathy) 01/2017
1	Dry Eye Syndromes (Dry Eye Syndrome) 04/2015
1	Retinal Neovascularization 04/2015
1	Myopia 11/2014
1	Oculomotor Nerve Diseases (Oculomotor Nerve Palsy) 01/2013
1	Partial Epilepsies (Epilepsy, Partial) 11/2009
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2009
1	Exfoliation Syndrome 01/2009
1	Low Tension Glaucoma 01/2009
1	Allergic Contact Dermatitis 08/2007
1	Dermatitis 08/2007

Drug/Important Bio-Agent (IBA)

6	Ophthalmic Solutions (Eye Drops)IBA 01/2019 - 06/2002
5	Brimonidine Tartrate (Alphagan)FDA LinkGeneric 01/2021 - 01/2009
5	brinzolamide (Azopt)FDA Link 01/2021 - 01/2012
5	trabecular meshwork-induced glucocorticoid response proteinIBA 01/2020 - 06/2013
3	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 01/2021 - 03/2011
3	Neuroprotective AgentsIBA 12/2018 - 06/2007
3	Retinaldehyde (Retinal)IBA 03/2016 - 09/2013
3	ProstaglandinsIBA 01/2016 - 04/2006
3	Timolol (Blocadren)FDA LinkGeneric 07/2014 - 06/2002
2	Antiglaucoma AgentsIBA 05/2015 - 05/2013
2	GanfortIBA 01/2015 - 07/2014
2	Bimatoprost (Lumigan)FDA Link 07/2014 - 10/2002
2	Benzalkonium Compounds (Benzalkonium Chloride)FDA LinkGeneric 01/2012 - 01/2012
2	Travoprost (Travatan)FDA Link 01/2012 - 06/2002
2	Carbonic Anhydrase InhibitorsIBA 01/2012 - 03/2011
2	formycin diphosphate (FDP)IBA 08/2006 - 10/2002
2	antiarrhythmic peptide (AAP)IBA 12/2003 - 10/2002
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2023
1	DNA (Deoxyribonucleic Acid)IBA 11/2021
1	Prostaglandins AIBA 01/2021
1	Acetazolamide (Diamox)FDA LinkGeneric 01/2019
1	Memantine (Namenda)FDA Link 12/2018
1	Biological FactorsIBA 01/2018
1	Drinking WaterIBA 08/2017
1	Ranibizumab (Lucentis)FDA Link 01/2017
1	LubricantsIBA 04/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2015
1	Topiramate (Topamax)FDA LinkGeneric 07/2014
1	polyquaternium 1 (polyquaternium-1)IBA 01/2012
1	hydroxide ionIBA 03/2011
1	ParasympathomimeticsIBA 03/2011
1	Vigabatrin FDA Link 11/2009
1	HomocysteineIBA 01/2009
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2009
1	Quaternary Ammonium CompoundsIBA 08/2007
1	Lidocaine (Xylocaine)FDA LinkGeneric 10/2005

Therapy/Procedure

5	Trabeculectomy (Trabeculoplasty) 01/2020 - 08/2007
5	Therapeutics 09/2015 - 01/2012
4	Lasers (Laser) 01/2020 - 05/2013
4	Filtering Surgery 07/2015 - 08/2007
3	Telescopes 05/2015 - 10/2007
1	Injections 01/2017
1	Laser Therapy (Surgery, Laser) 07/2015
1	Intraocular Injections 04/2015
1	Anesthesia 01/2013
1	Local Anesthesia 01/2013
1	Drug Prescriptions 10/2010
1	Contact Lenses 12/2006